• OPEN AN ACCOUNT
Indian Indices
Sensex
78,428.95 -210.08
( -0.27%)
Global Indices
Nasdaq
53,210.99 704.96
(1.34%)
Dow Jones
7,621.51 110.79
(1.48%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,850.37 -17.68
(-0.16%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Sanofi India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500674
INE058A01010
325.3278333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SANOFI
23.71
7795.19
EPS(TTM)
Face Value()
Div & Yield %
142.76
10
3.63
 

Sanofi India jumps after Nippon India MF adds stake
Jun 15,2026
According to exchange data, Nippon India Mutual Fund purchased 2.64 lakh shares, or 1.15% equity, of Sanofi India at Rs 3,150 per share through a bulk deal on 12 June 2026.

The shares were sold by HDFC Life Insurance Company, which offloaded 2.75 lakh shares, or 1.19% equity, at the same price.

As of the March 2026 quarter, Nippon India Small Cap Fund held an aggregate 3.79% stake in Sanofi India, while HDFC Life Insurance Company's Shareholders Solvency Margin Account owned 1.47% of the pharmaceutical company.

Sanofi India is engaged in the manufacture and marketing of pharmaceutical products and vaccines. On a standalone basis, Sanofi India's net profit declined 14.14% to Rs 102.60 crore while net sales declined 11.87% to Rs 472.30 crore in Q4 March 2026 over Q4 March 2025.